B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Mianserin

A tetracyclic compound with antidepressant effects. It may cause drowsiness and hematological problems. Its mechanism of therapeutic action is not well understood, although it apparently blocks alpha-adrenergic, histamine H1, and some types of serotonin receptors.

299 PubMed studies analyzed · 45 RCTs · Evidence Score: 47.8

Research Domains

Mianserin has been studied across 14 research domains including 🌤️ Mood & Depression, 🧠 Focus & Attention, 😴 Sleep, ❤️ Cardiovascular, 💊 Pain. The primary research focus is 🌤️ Mood & Depression with 41% of studies addressing this area.

Loading evidence profile...

This evidence profile for Mianserin is generated deterministically from 299 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.